OFI Technologie & Innovation GmbH

The research and testing institute OFI provides assistance for the targeted, efficient development of new products, prioritizing customer concerns as a 100% privately owned, independent, self-funded laboratory rather than developing its own products. Whether medicines are in development, authorization or already on the market, OFI offers international services based on GMP, EMA and US guidelines, including quality control and development (drug release and raw material testing, method development and validation, stability assessment studies), pharmaceutical packaging (material release testing, CCI testing, extractables and leachables), medical devices (biocompatibility testing), and investigations through its Expert Center for particles, impurities and nitrosamines.